Decision Diagnostics Corp.

OTC: DECN

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Dec 1, 2021, 1:55 p.m.

/zigman2/quotes/210557282/composite

$

0.0003

Change

0.00 0.00%

Volume

Volume 80,670

Quotes are delayed by 20 min

/zigman2/quotes/210557282/composite

Previous close

$ 0.0003

$ 0.0003

Change

0.00 0.00%

Day low

Day high

$0.0003

$0.0003

Open

52 week low

52 week high

$0.0001

$0.13

Open

Company Description

Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. It provides blood glucose home testing test strips and exciting new concepts for blood testing monitors. The company diagnostics also provides smart phone based electronic medical record ap...

Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. It provides blood glucose home testing test strips and exciting new concepts for blood testing monitors. The company diagnostics also provides smart phone based electronic medical record applications which allow physicians to carry access and update their patients' histories, medication data and best care guidelines at the point of care. Decision Diagnostics was founded on July 6, 2000 and is headquartered in Los Angeles, CA.

Valuation

Price to Sales Ratio

2.42

Price to Book Ratio

11.32

Enterprise Value to EBITDA

-1.04

Enterprise Value to Sales

1.18

Total Debt to Enterprise Value

0.41

Efficiency

Receivables Turnover

1.99

Total Asset Turnover

0.36

Liquidity

Current Ratio

0.33

Quick Ratio

0.30

Cash Ratio

0.11

Profitability

Gross Margin

10.02

Operating Margin

-122.06

Pretax Margin

-1,498.91

Net Margin

-1,499.05

Return on Assets

-533.45

Return on Equity

-8,065.67

Return on Total Capital

-71.14

Return on Invested Capital

-8,065.67

Capital Structure

Total Debt to Total Equity

517.67

Total Debt to Total Capital

83.79

Total Debt to Total Assets

51.00

Officers and Executives

Name Age Officer Since Title
Mr. Keith M. Berman 64 2003 Chief Financial Officer, Secretary & Director
Mr. Robert Jagunich 71 2003 Director

Insider Actions

– Purchase – Sale 1 – Number of Transactions
/news/latest/company/us/decn

MarketWatch News on DECN

  1. CEO charged in alleged COVID-19 fraud scheme

    5:04 p.m. Dec. 18, 2020

    - Claudia Assis

/news/nonmarketwatch/company/us/decn

Other News on DECN

At a Glance

Decision Diagnostics Corp.

2660 Townsgate Road

Suite 300

Westlake Village

Los Angeles, California 91361

Phone

1 8054461973

Industry

Computer Services

Sector

Business/Consumer Services

Fiscal Year-end

12/2021

Revenue

$1.98M

Net Income

$-29.67M

Employees

-

/news/pressrelease/company/us/decn

Press Releases on DECN

  1. Decision Diagnostics Deadline Alert

    6:08 a.m. March 16, 2021

    - Newsfile Corp

  2. Decision Diagnostics Class Action Reminder

    7:44 a.m. March 14, 2021

    - Newsfile Corp

  3. Decision Diagnostics Shareholder Notice

    8:32 a.m. March 13, 2021

    - Newsfile Corp

  4. Decision Diagnostics Shareholder Alert

    7:37 p.m. March 11, 2021

    - Newsfile Corp

  5. Decision Diagnostics Deadline Alert

    7:37 p.m. March 10, 2021

    - Newsfile Corp

  6. Loading more headlines...
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.